Related Experiment Videos
The pineal hormone melatonin in panic disorder
Journal of Affective Disorders
|May 1, 1987
Summary
Patients with panic disorder show lower melatonin levels during the night compared to controls. This suggests a potential defect in beta-adrenergic receptor sensitivity or sympathetic transmission in panic disorder.
Area of Science:
- Neuroendocrinology
- Psychiatry
- Sleep Medicine
Background:
- Melatonin, a pineal hormone, regulates circadian rhythms and exhibits nocturnal synthesis.
- Panic disorder is a psychiatric condition characterized by recurrent, unexpected panic attacks.
- Alterations in neuroendocrine function may be implicated in the pathophysiology of panic disorder.
Purpose of the Study:
- To investigate nocturnal melatonin synthesis in patients with panic disorder.
- To compare melatonin levels between individuals with panic disorder and healthy controls.
Main Methods:
- Salivary melatonin concentrations were measured in 11 patients with panic disorder and 8 control subjects.
- Sampling occurred hourly from 8 p.m. to midnight.
- Statistical analysis included Kruskal-Wallis one-way ANOVA.
Main Results:
- Melatonin levels were significantly lower in patients with panic disorder at 10 p.m. (P < 0.05) and midnight (P < 0.01) compared to controls.
- Lower, but not statistically significant, melatonin concentrations were observed at 9 p.m. (P = 0.09) and 11 p.m.
Conclusions:
- Patients with panic disorder may exhibit reduced nocturnal melatonin synthesis.
- These findings suggest a potential generalized defect in beta-adrenergic receptor sensitivity or sympathetic transmission in panic disorder.
- Further research is warranted to explore the neuroendocrine underpinnings of panic disorder.